Delivery Order SPE2DR25D2005-SPE2DR26FF1R7
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on January 5, 2026, by the Defense Logistics Agency to supply 100 capsules of Dextroamphetamine-Amphetamine 10 mg with a ceiling value of $1,231.74. The contract is firm fixed price, non-competitive set-aside, and scheduled for completion by January 6, 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,305.54 by the Defense Logistics Agency (DLA) on October 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets in quantities of 100 units, with a ceiling value of $1,396.35 and an ultimate completion date of December 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 6, 2026, for dextroamphetamine-amphetamine 15 mg capsules (100-count bottles) with a ceiling value of $1,125.13. This firm fixed-price delivery order, which has an ultimate completion date of January 7, 2026, represents a task order issued under a larger Indefinite Delivery Contract vehicle. The contract was not set...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100 count) with a ceiling value of $1,850.20. This firm fixed-price contract was awarded on January 12, 2026, with a completion date of January 13, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,316.42 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 10 mg tablets (100 count) on August 28, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a $1,377.89 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count units), with a completion date of August 18, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets (100-count bottles) with a ceiling value of $1,187.03. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 24, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100, with a ceiling value of $2,114.40. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,966.33 for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on August 7, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1R7Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 26, 2026, for the supply of Dextroamphetamine-Amphetamine 10 mg tablets (100-count packaging) with a ceiling value of $1,620.52. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 27, 2026, and was competitively awarded with no set-aside designation. This award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. The delivery order supports the Defense Logistics Agency's medical supply chain mission, which serves military treatment facilities, veteran healthcare programs, and other federal medical institutions globally. AmerisourceBergen's extensive federal contract portfolio demonstrates its established capability to fulfill government pharmaceutical procurement requirements across multiple therapeutic domains, including neurological treatments, pain management, diabetes medications, and controlled substances. The firm fixed-price structure and rapid completion timeline reflect the standardized operational model through which the Defense Logistics Agency's prime vendors efficiently deliver essential medical commodities to support military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/25/26 |